Atlas Trials

CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL

Clinical trial NCT04995536 · WITHDRAWN

Trial details

NCT number
NCT04995536
Sponsor
City of Hope Medical Center
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Grade 3a Follicular LymphomaRecurrent Grade 3b Follicular LymphomaRecurrent Mantle Cell LymphomaRecurrent Marginal Zone LymphomaRecurrent Small Lymphocytic LymphomaRefractory B-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell Lymphoma
Start date
2021-07-27
Primary completion
2024-01-04
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.